McAdam LLC’s Vicarious Surgical RBOT Stock Holding History

McAdam LLC’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-763	Closed	-$13.5K	–	285
2023 Q3	$13.5K	Hold	763	–	–	﹤0.01%	256
2023 Q2	$41.9K	Buy	+763	New	+$48.6K	﹤0.01%	256

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

McAdam LLC's RBOT Position: Q4 2023 in Review

McAdam LLC sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 763 shares — an estimated $13.5K sold.

McAdam LLC first reported a position in RBOT in Q2 2023 and held it in 2 quarters. The position peaked at $41.9K in Q2 2023. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

McAdam LLC reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
McAdam LLC sold 763 Vicarious Surgical shares in Q4 2023, an estimated $13.5K.
McAdam LLC first reported a position in Vicarious Surgical in Q2 2023 and held it in 2 quarters.
McAdam LLC's Vicarious Surgical position peaked at $41.9K in Q2 2023.
72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on McAdam LLC's 13F filing for Q4 2023, filed 5 Feb 2024.